Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Are Associated With Early Carotid Atherosclerosis
- 1 March 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 25 (3) , 617-621
- https://doi.org/10.1161/01.atv.0000154486.03017.35
Abstract
Objective— Growth hormone (GH)–insulin-like growth factor (IGF)-1 axis regulates growth and survival of vascular cells and cardiomyocytes. The role of GH–IGF-1 axis in cardiovascular disease is controversial. Methods and Results— We assessed the association of circulating levels of IGF-1 and IGF binding protein-3 (IGFBP-3) with early carotid atherosclerosis and atherosclerotic risk factors in 330 Japanese men (age 51.6±8.6 years, range 29 to 77, body mass index [BMI] 23.6±2.9 kg/m2). Intima-media thickness (IMT) of the common carotid artery was measured by ultrasound. Abdominal visceral adipose and subcutaneous adipose tissue area by computer-assisted tomographic scan were determined. Correlation coefficients were calculated by partial correlation analysis. BMI and plasma insulin showed positive associations with circulating IGF-1 and IGFBP-3. Subcutaneous adipose tissue was correlated with IGF-1. High-density lipoprotein cholesterol was inversely associated with IGF-1. Blood pressure, total cholesterol, ... The role of growth hormone–insulin-like growth factor (IGF)-1 axis in cardiovascular disease is controversial. We have found that IGF-1 and IGF binding protein (IGFBP)-3 were associated with carotid intima-media thickness independent of age, body mass index, blood pressure, and insulin in 330 apparently healthy Japanese men. Circulating IGF-1 and IGFBP-3 may be stimulators of atherosclerosis.Keywords
This publication has 29 references indexed in Scilit:
- Expression, Regulation, and Function of IGF-1, IGF-1R, and IGF-1 Binding Proteins in Blood VesselsArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Cardiovascular Function in AcromegalyEndocrine Reviews, 2003
- Cardiovascular Disease and Insulin-Like Growth Factor ICirculation, 2002
- Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarctionJournal of the American College of Cardiology, 2001
- Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatmentJournal of the American College of Cardiology, 2000
- Oligoclonal T Cell Expansions in Atherosclerotic Lesions of Apolipoprotein E–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A ReviewJournal of Clinical Endocrinology & Metabolism, 1998
- Insulin-Like Growth Factor-I, Insulin, and Angina Pectoris Secondary to Coronary Atherosclerosis, Vasospasm, and Syndrome XThe American Journal of Cardiology, 1997
- Insulin-like growth factor-1 and angiographically documented coronary artery diseaseThe American Journal of Cardiology, 1996
- Premature mortality due to cardiovascular disease in hypopituitarismThe Lancet, 1990